BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2511098)

  • 1. Prevention of non-hemolytic transfusion reactions with leucocyte-poor blood: a prospective study.
    Reverberi R; Ferrari L; Gennari M; Menini C
    Haematologica; 1989; 74(3):283-8. PubMed ID: 2511098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study on the use of leucocyte-filters in reducing blood transfusion reactions in multi-transfused thalassemic children.
    Tan KK; Lee WS; Liaw LC; Oh A
    Singapore Med J; 1993 Apr; 34(2):109-11. PubMed ID: 8266145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of filtration in the provision of leukocyte poor red cells to multitransfused patients.
    James J; Matthews RN; Holdsworth RF; Fulton A; Tauro GP; Hussein S; McGrath KM
    Pathology; 1986 Jan; 18(1):127-30. PubMed ID: 3725421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multistate cluster of red blood cell transfusion reactions associated with use of a leucocyte reduction filter.
    Alvarado-Ramy F; Kuehnert MJ; Alonso-Echanove J; Sledge L; Haley NR; Epstein J; Vostal J; Pearson M
    Transfus Med; 2006 Feb; 16(1):41-8. PubMed ID: 16480438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of leukocyte poor blood: I. Effect on frequency and severity of non hemolytic transfusion reactions.
    Reverberi R; Moretti M; Ferrari L; Menini C
    Riv Emoter Immunoematol; 1983; 30(1):39-49. PubMed ID: 6635479
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of leukocyte-reduction on the transfusion reactions to red blood cells concentrates].
    Mukagatare I; Monfort M; de Marchin J; Gerard C
    Transfus Clin Biol; 2010 Feb; 17(1):14-9. PubMed ID: 20106700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial of young red blood cells prepared by apheresis.
    Pisciotto P; Kiraly T; Paradis L; Kakaiya RM; Rink L; Pearson HA
    Ann Clin Lab Sci; 1986; 16(6):473-8. PubMed ID: 3541773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of hydroxyurea in providing transfusion independence in β-thalassemia.
    Ansari SH; Shamsi TS; Ashraf M; Perveen K; Farzana T; Bohray M; Erum S; Mehboob T
    J Pediatr Hematol Oncol; 2011 Jul; 33(5):339-43. PubMed ID: 21602718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-storage leucocyte depletion and transfusion reaction rates in cancer patients.
    Da Ponte A; Bidoli E; Talamini R; Steffan A; Abbruzzese L; Toffola RT; De Marco L
    Transfus Med; 2005 Feb; 15(1):37-43. PubMed ID: 15713127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A new separation protocol (DRBCP-F) for automated blood component donation with the MCS 3p cell separator for collection of leukocyte depleted erythrocyte concentrates and plasma].
    Zeiler T; Kretschmer V
    Beitr Infusionsther Transfusionsmed; 1997; 34():118-22. PubMed ID: 9417335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of leucocyte poor blood. A comparison of five different methods.
    Grunnet N; Rasmussen NJ
    Scand J Urol Nephrol Suppl; 1981; 64():106-11. PubMed ID: 6959257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical effects of different types of red cell concentrates in patients with thalassemia and sickle cell disease.
    Cabibbo S; Fidone C; Antolino A; Manenti OG; Garozzo G; Travali S; Bennardello F; Di Stefano R; Bonomo P
    Transfus Clin Biol; 2007 Dec; 14(6):542-50. PubMed ID: 18434227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion reactions in thalassemia. A survey from the Cooleycare programme. The Cooleycare Cooperative Group.
    Rebulla P
    Haematologica; 1990; 75 Suppl 5():122-7. PubMed ID: 2086372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red cell immunization in multiply transfused Malay thalassemic patients.
    Noor Haslina MN; Ariffin N; Illuni Hayati I; Rosline H
    Southeast Asian J Trop Med Public Health; 2006 Sep; 37(5):1015-20. PubMed ID: 17333748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of two types of leukocyte removal filters on transfusion dependent thalassaemics.
    Jamal R; Mazeni NR; Hussin H
    Malays J Pathol; 2000 Dec; 22(2):79-83. PubMed ID: 16329539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood component therapy: differential indication for erythrocyte transfusion].
    Bergmann H
    Infusionsther Klin Ernahr; 1980 Aug; 7(4):184-9. PubMed ID: 7191413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red cell autoantibodies among thalassaemia patients in Hospital Universiti Sains Malaysia.
    Noor Haslina MN; Ariffin N; Illuni Hayati I; Rosline H
    Singapore Med J; 2007 Oct; 48(10):922-5. PubMed ID: 17909677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate transfusion reactions.
    Climent-Peris C; Vélez-Rosario R
    P R Health Sci J; 2001 Sep; 20(3):229-35. PubMed ID: 11776724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocyte-poor blood.
    Wenz B
    Crit Rev Clin Lab Sci; 1986; 24(1):1-20. PubMed ID: 3539518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microchimerism in immune competent patients related to the leukocyte content of transfused red blood cell concentrates.
    Flesland O; Ip LS; Storlien AS; Spurkland A; Larsen J; Solheim BG
    Transfus Apher Sci; 2004 Dec; 31(3):173-80. PubMed ID: 15556463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.